NCT06388967Recruiting
Pancreatic Cancer Detection Consortium
Early Detection of Pancreatic Cancer: Prospective Study
Source: ClinicalTrials.gov · Last updated 28 Sept 2026
Brief summary (registry, in English)
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 19 Apr 2024
- Start date
- 15 Mar 2023
- Primary completion date
- 30 Dec 2030
- Lead sponsor
- City of Hope Medical Center
- Diseases
- Pancreatic cancer
- NCT number
- NCT06388967
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 15 Mar 2023 to the primary completion date, 30 Dec 2030
- 13 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Lack of written informed consent.
Who the study is looking for
- Histological diagnosis of pancreatic ductal adenocarcinoma, stages I-IV (TNM classification, 8th edition)
- Received standard diagnostic and staging procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment.
- Imaging- or endoscopy-based proof of lack of pancreatic ductal adenocarcinoma at the time of sampling (Non-disease controls)
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (13)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nagoya University Coordinator of this site? Confirm its status | Nagoya | Japan | Recruiting |
| Asan Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
| Ochsner Medical Center Coordinator of this site? Confirm its status | Jefferson | United States | Recruiting |
| Medical College of Wisconsin Coordinator of this site? Confirm its status | Milwaukee | United States | Recruiting |
| City of Hope Medical Center Coordinator of this site? Confirm its status | Monrovia | United States | Recruiting |
| Atlantic Health System Coordinator of this site? Confirm its status | Morristown | United States | Recruiting |
| Hoag Center Coordinator of this site? Confirm its status | Newport Beach | United States | Terminated |
| OSF HealthCare Coordinator of this site? Confirm its status | Peoria | United States | Recruiting |
| Translational Genomics Research Institute Coordinator of this site? Confirm its status | Phoenix | United States | Recruiting |
| AHN Cancer Institute at Allegheny General Hospital Coordinator of this site? Confirm its status | Pittsburgh | United States | Recruiting |
| Piedmont Medical Center Coordinator of this site? Confirm its status | Rock Hill | United States | Recruiting |
| HonorHealth Coordinator of this site? Confirm its status | Scottsdale | United States | Terminated |
| MultiCare Cancer Institute - Tacoma General Hospital Coordinator of this site? Confirm its status | Tacoma | United States | Recruiting |
Related publications
- Liquid biopsy for early detection of pancreatic ductal adenocarcinoma.Nat Med · 2026 · PMID 42749887
This page is information, not medical advice. Discuss any trial with your doctor.